UP.AIACT.IN
![[and more...] (3).png](https://static.wixstatic.com/media/f0525d_a8e80b852d194395a9eebf462f119e10~mv2.png/v1/crop/x_46,y_517,w_3104,h_1725/fill/w_980,h_545,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/%5Band%20more___%5D%20(3).png)
28 Stakeholders. 4 Editors. 10 Sectors. 1 Uttar Pradesh.
India's first AI Transformation Report and Matrix on the State of Uttar Pradesh, India
The AI Transformation Matrix: Problem Statements
Powered by AIACT.IN, the matrix offers a consolidated version of 77 distinct recommendations in the form of "Sectoral Playbooks" from the UP.AIACT.IN Report 2026.
Hospital Infrastructure, Advanced Pharmaceuticals
Problem Statement
State capital expenditure is routinely diluted into general hospital IT, leaving the state without physically separate infrastructure for advanced clinical trials and creating massive bottlenecks in identifying eligible patient cohorts.
What is the plausible risk of ignoring the Problem Statement?
Allowing clinical research funding to be consumed by general hospital IT upgrades, or failing to deploy proper EMR anonymization protocols which compromises data safety.
Here's what the UP.AIACT.IN Report 2026 Recommends.
Earmark funds exclusively to construct physically separate, dedicated clinical trial wards within high footfall institutions like KGMU, SGPGIMS, and BHU IMS. Systematically deploy AI driven data extraction and anonymization tools across the Electronic Medical Records (EMRs) of state medical colleges.
What can the UP Government consider as a Policy Mandate based on our specific Recommendation?
The administration must prohibit the dilution of state capital expenditure into generic healthcare IT, mandating instead the deployment of algorithmic matching tools to parse complex trial criteria against strictly anonymized patient datasets.
What's the AI Intervention Layer in this Recommendation?
Deployment of AI data extraction pipelines and automated cohort matching algorithms over unified, anonymized EMR databases.
Here's how our stakeholders measured impact of our specific Recommendation.
Global pharma companies secure instantaneous identification of viable cohorts and seamless access to compliant Phase II and III infrastructure without placing additional burdens on standard public healthcare operations.
What can be some possible Economic Spillover if our Recommendation is implemented?
Directly transforms the unprecedented demographic scale of Uttar Pradesh into a highly monetizable, data driven asset for the global life sciences ecosystem.
In which Chapter of the UP.AIACT.IN Report 2026 can you find this recommendation?
Chapter 8